Hemgenix continues to be specified ‘conditional authorisation’. Which means that the European Medicines Agency decided that the many benefits of Hemgenix are bigger than its challenges, but the organization must supply supplemental evidence after authorisation.When given on the patient, the virus will carry the variable IX gene on the liver cel